An overview of EMcision Boston Scientific (BSX) announced the acquisition of EMcision on March 5, 2018. EMcision is a privately held company based in the United Kingdom and Canada. The company’s flagship product, the HabibTM EndoHPB probe, is used during the treatment of pancreaticobiliary cancer. Pancreaticobiliary cancer patients often develop jaundice due to bile duct blockage as […]
